Overview

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic profile of oral doses of AZD7295 capsules in healthy subjects, and also to assess the effects of food as well as safety and tolerability.
Phase:
Phase 1
Details
Lead Sponsor:
Arrow Therapeutics